- Home
- QURE vs UTG Comparison
QURE vs UTG Comparison
Compare QURE & UTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QURE | UTG |
|---|---|---|
| Founded | 1998 | N/A |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.3B |
| IPO Year | 2013 | 2003 |
Fundamental Metrics
Financial Performance| Metric | QURE | UTG |
|---|---|---|
| Price | $22.67 | $35.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $66.91 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 388.2K |
| Earning Date | 11-09-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $56.20 | N/A |
| Revenue Next Year | $357.08 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $33.53 |
| 52 Week High | $71.50 | $43.90 |
Technical Indicators
Market Signals| Indicator | QURE | UTG |
|---|---|---|
| Relative Strength Index (RSI) | 16.51 | N/A |
| Support Level | $21.91 | N/A |
| Resistance Level | $27.66 | N/A |
| Average True Range (ATR) | 2.17 | 0.00 |
| MACD | -2.39 | 0.00 |
| Stochastic Oscillator | 5.34 | 0.00 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About UTG Reaves Utility Income Fund of Beneficial Interest
Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.